Maddrey Score
The Maddrey Score estimates short‑term mortality risk in alcoholic hepatitis to identify patients who may benefit from corticosteroid therapy.
Indicaciones de Uso
Indicated to assess severity of alcoholic hepatitis and identify candidates for corticosteroids when score ≥32, which reflects a 30–50% 28‑day mortality 1 [Level I evidence]. Used to separate severe from mild/moderate disease and predict short‑term prognosis, guiding whether to initiate prednisolone 2 [Level I evidence]. A value <32 suggests lower short‑term risk and need for supportive care alone.
Información y Precauciones
Identifies severe alcoholic hepatitis when markedly elevated values indicate ~30–50% 28‑day mortality and potential steroid benefit (AASLD guidance) 1. Caution: misses renal dysfunction, is inferior to MELD/ABIC/GAHS for prognostication (STOPAH; 1,068 pts) 2, varies with control PT, and offers poor long‑term prediction. High scores risk overtreatment; low scores are not benign.